Scientific paper 93 – Use of a Human Influenza Challenge Model to Assess Person-to-Person Transmission: Proof-of-Concept StudyNovember 7, 2016 3:08 pm
Authors -Ben Killingley,1 Joanne E. Enstone,1 Jane Greatorex,2 Anthony S. Gilbert,3 Rob Lambkin-Williams,3 Simon Cauchemez,4 Jacqueline M. Katz,5 Robert Booy,6 Andrew Hayward,7 John Oxford,8 Carolyn B. Bridges,5 Neil M. Ferguson,4 and Jonathan S. Nguyen Van-Tam1
1 Division of Epidemiology and Public Health, University of Nottingham,
2 Clinical Microbiology and Public Health, Addenbrooke’s Hospital, Cambridge,
3 hVIVO plc formerly Retroscreen Virology Ltd, Queen Mary BioEnterprises, Innovation Centre, London,
4 School of Public Health, Imperial College London, United Kingdom;
5 Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia;
6 National Centre for Immunisation Research and Surveillance, Westmead, Australia;
7 Centre for Infectious Disease Epidemiology, University College London,
8 Centre for Infectious Diseases, Bart’s and the London, Queen Mary’s School of Medicine and Dentistry, London, United Kingdom
To view this scientific paper in full please click here
Influenza transmission in humans remains poorly understood. In particular, the relative contribution of contact, large droplet, and aerosol transmission is unknown. The aims of this proof-of-concept study were to determine whether an experimentally induced influenza infection is transmissible between humans and whether this would form a viable platform for future studies.
In a quarantine facility, healthy volunteers (‘‘donors’’) were inoculated with A/Wisconsin/67/2005 (H3N2) influenza virus via intranasal drops. On study days 2 and 3 ‘‘recipient’’ volunteers were exposed to donors under close living conditions. Volunteers socialized for 30 hours during a 2-day period. Infection was confirmed by $1 positive results from polymerase chain reaction, virus culture, or serology.
After inoculation, 4 of 9 donors developed symptoms consistent an influenza-like illness (ILI) and 7 of 9 were proven to be influenza-infected. After exposure, 4 of 15 recipients developed symptoms of ILI and 3 of 15 were proven to be infected. Serum collected within 2 days of study initiation indicated that 1 donor and 3 recipients were seropositive at study initiation. After adjustment for preexposure immunity, the overall secondary attack rate was 25% (3 of 12).
Experimental human exposure studies offer an attractive potential method for answering outstanding questions related to influenza transmission and the evaluation of interventions to reduce it.